Literature DB >> 27002148

A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells.

Nathalie Sakakini1, Laurent Turchi2, Aurélie Bergon3, Hélène Holota3, Samah Rekima2, Fabrice Lopez3, Philipe Paquis4, Fabien Almairac4, Denys Fontaine5, Nathalie Baeza-Kallee6, Ellen Van Obberghen-Schilling2, Marie-Pierre Junier7, Hervé Chneiweiss7, Dominique Figarella-Branger8, Fanny Burel-Vandenbos9, Jean Imbert10, Thierry Virolle11.   

Abstract

Glioblastomas are the most common primary brain tumors, highly vascularized, infiltrating, and resistant to current therapies. This cancer leads to a fatal outcome in less than 18 months. The aggressive behavior of glioblastomas, including resistance to current treatments and tumor recurrence, has been attributed to glioma stemlike/progenitor cells. The transcription factor EGR1 (early growth response 1), a member of a zinc finger transcription factor family, has been described as tumor suppressor in gliomas when ectopically overexpressed. Although EGR1 expression in human glioblastomas has been associated with patient survival, its precise location in tumor territories as well as its contribution to glioblastoma progression remain elusive. In the present study, we show that EGR1-expressing cells are more frequent in high grade gliomas where the nuclear expression of EGR1 is restricted to proliferating/progenitor cells. We show in primary cultures of glioma stemlike cells that EGR1 contributes to stemness marker expression and proliferation by orchestrating a PDGFA-dependent growth-stimulatory loop. In addition, we demonstrate that EGR1 acts as a positive regulator of several important genes, including SHH, GLI1, GLI2, and PDGFA, previously linked to the maintenance and proliferation of glioma stemlike cells.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer biology; cancer stem cells; cell proliferation; cell signaling; transcription factor

Mesh:

Substances:

Year:  2016        PMID: 27002148      PMCID: PMC4865916          DOI: 10.1074/jbc.M116.720698

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles.

Authors:  Albin Sandelin; Wynand Alkema; Pär Engström; Wyeth W Wasserman; Boris Lenhard
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

3.  The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.

Authors:  M Fareh; L Turchi; V Virolle; D Debruyne; F Almairac; S de-la-Forest Divonne; P Paquis; O Preynat-Seauve; K-H Krause; H Chneiweiss; T Virolle
Journal:  Cell Death Differ       Date:  2011-07-01       Impact factor: 15.828

4.  ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.

Authors:  Nir Ben-Chetrit; Gabi Tarcic; Yosef Yarden
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

5.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling.

Authors:  T Virolle; E D Adamson; V Baron; D Birle; D Mercola; T Mustelin; I de Belle
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

6.  Nitric oxide-induced programmed cell death in human neuroblastoma cells is accompanied by the synthesis of Egr-1, a zinc finger transcription factor.

Authors:  Giuseppe Cibelli; Vincenza Policastro; Oliver G Rössler; Gerald Thiel
Journal:  J Neurosci Res       Date:  2002-02-15       Impact factor: 4.164

7.  The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.

Authors:  Shwetal Mehta; Emmanuelle Huillard; Santosh Kesari; Cecile L Maire; Diane Golebiowski; Emily P Harrington; John A Alberta; Michael F Kane; Matthew Theisen; Keith L Ligon; David H Rowitch; Charles D Stiles
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

8.  Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer.

Authors:  Motoko Seto; Miki Ohta; Yoshinari Asaoka; Tsuneo Ikenoue; Motohisa Tada; Koji Miyabayashi; Dai Mohri; Yasuo Tanaka; Hideaki Ijichi; Keisuke Tateishi; Fumihiko Kanai; Takao Kawabe; Masao Omata
Journal:  Mol Carcinog       Date:  2009-08       Impact factor: 4.784

9.  CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.

Authors:  Cristina Patru; Luciana Romao; Pascale Varlet; Laure Coulombel; Eric Raponi; Josette Cadusseau; François Renault-Mihara; Cécile Thirant; Nadine Leonard; Alain Berhneim; Maria Mihalescu-Maingot; Jacques Haiech; Ivan Bièche; Vivaldo Moura-Neto; Catherine Daumas-Duport; Marie-Pierre Junier; Hervé Chneiweiss
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

10.  Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

Authors:  Ainslie Mitchell; Crispin R Dass; Lun-Quan Sun; Levon M Khachigian
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

View more
  20 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine.

Authors:  Deguan Lv; Ryan C Gimple; Cuiqing Zhong; Qiulian Wu; Kailin Yang; Briana C Prager; Bhaskar Godugu; Zhixin Qiu; Linjie Zhao; Guoxin Zhang; Deobrat Dixit; Derrick Lee; Jia Z Shen; Xiqing Li; Qi Xie; Xiuxing Wang; Sameer Agnihotri; Jeremy N Rich
Journal:  Dev Cell       Date:  2022-06-03       Impact factor: 13.417

3.  Identification of microRNA expression profiles of CD44+ ovarian cancer stem cells.

Authors:  Luyao Wang; Xiaogai Zhi; Yingying Lu; Yu Cong; Ziyi Fu; Jian Cao; Sujuan Xu; Juan Lv; Hongjie Ruan
Journal:  Arch Gynecol Obstet       Date:  2022-01-25       Impact factor: 2.493

4.  PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.

Authors:  Ran Xu; Jianxiong Ji; Xin Zhang; Mingzhi Han; Chao Zhang; Yangyang Xu; Yuzhen Wei; Shuai Wang; Bin Huang; Anjing Chen; Di Zhang; Qing Zhang; Wenjie Li; Zheng Jiang; Jian Wang; Xingang Li
Journal:  J Exp Clin Cancer Res       Date:  2017-12-28

5.  MEIS homeodomain proteins facilitate PARP1/ARTD1-mediated eviction of histone H1.

Authors:  Ann-Christin Hau; Britta Moyo Grebbin; Zsuzsa Agoston; Marie Anders-Maurer; Tamara Müller; Anja Groß; Jasmine Kolb; Julian D Langer; Claudia Döring; Dorothea Schulte
Journal:  J Cell Biol       Date:  2017-07-24       Impact factor: 10.539

6.  Impairment of the activin A autocrine loop by lopinavir reduces self-renewal of distinct human adipose progenitors.

Authors:  Christophe Ravaud; Martin Paré; Stéphane Azoulay; Christian Dani; Annie Ladoux
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

7.  miR‑196a‑5p modulates gastric cancer stem cell characteristics by targeting Smad4.

Authors:  Yunzhi Pan; Xiong Shu; Lichao Sun; Long Yu; Lixin Sun; Zhihua Yang; Yuliang Ran
Journal:  Int J Oncol       Date:  2017-04-19       Impact factor: 5.650

8.  EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.

Authors:  Juanhong Zhao; Haixia Li; Miao Yuan
Journal:  Genes Genomics       Date:  2021-03-09       Impact factor: 1.839

9.  Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter.

Authors:  Dian-Gang Chen; Bo Zhu; Sheng-Qing Lv; Hongfan Zhu; Jinliang Tang; Changlin Huang; Qingrui Li; Pu Zhou; Dong-Lin Wang; Guang-Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2017-12-15

10.  A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma.

Authors:  Wenna Guo; Xijia Chen; Liucun Zhu; Qiang Wang
Journal:  Oncotarget       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.